Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

IL23R: a susceptibility locus for celiac disease and multiple sclerosis?

Abstract

Recent studies have shown association of the IL23R gene with inflammatory bowel disease, psoriasis and ankylosing spondylitis. We aimed at studying the involvement of IL23R in celiac disease (CD) and multiple sclerosis (MS). We performed a case–control study including 598 patients with CD, 414 with MS and 546 healthy controls, all of them white Spaniards. All samples were genotyped for two single nucleotide polymorphisms: rs7517847 and rs11209026 (Arg381Gln). Statistical analyses were performed using χ2-tests or the Fisher's exact test. The minor allele (Gln) of the coding variant Arg381Gln was significantly increased in CD and MS patients when compared to controls (8% in CD vs 6% in controls, P=0.02; 9% in MS, P=0.006). In MS, a stronger effect was observed in patients showing primary-progressive disease (16%, P=0.004). Moreover, heterozygotes for rs7517847 were significantly increased in this group of MS patients (81% in MS vs 48% in controls, P=0.0002). In conclusion, contrary to what has been described previously, the less frequent allele of the functional polymorphism Arg381Gln (rs11209026) seems to be increasing susceptibility to CD and MS, although in this last group of patients a stronger effect is observed in patients affected of a primary-progressive form.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13: 715–725.

    Article  CAS  Google Scholar 

  2. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8: 950–957.

    Article  CAS  Google Scholar 

  3. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461–1463.

    Article  CAS  Google Scholar 

  4. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80: 273–290.

    Article  CAS  Google Scholar 

  5. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39: 1329–1337.

    Article  CAS  Google Scholar 

  6. Nilsen EM, Jahnsen FL, Lundin KE, Johansen FE, Fausa O, Sollid LM et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998; 115: 551–563.

    Article  CAS  Google Scholar 

  7. Kahl KG, Kruse N, Toyka KV, Rieckmann P . Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis. J Neurol Sci 2002; 200: 53–55.

    Article  CAS  Google Scholar 

  8. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909–911.

  9. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–231.

    Article  CAS  Google Scholar 

  10. Weersma RK, Zhernakova A, Nolte IM, Lefebvre C, Rioux JD, Mulder F et al. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands. Am J Gastroenterol 2007 [E-pub ahead of print].

  11. Begovich AB, Chang M, Caillier SJ, Lew D, Catanese JJ, Wang J et al. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum Immunol 2007; 68: 934–937.

    Article  CAS  Google Scholar 

  12. Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005; 37: 1341–1344.

    Article  CAS  Google Scholar 

  13. Hunt KA, Monsuur AJ, McArdle WL, Kumar PJ, Travis SP, Walters JR et al. Lack of association of MYO9B genetic variants with coeliac disease in a British cohort. Gut 2006; 55: 969–972.

    Article  CAS  Google Scholar 

  14. Fernandez-Arquero M, Arroyo R, Rubio A, Martin C, Vigil P, Conejero L et al. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 1999; 53: 1361–1363.

    Article  CAS  Google Scholar 

  15. Martinez A, Rubio A, Urcelay E, Fernandez-Arquero M, De Las Heras V, Arroyo R et al. TNF-376A marks susceptibility to MS in the Spanish population: a replication study. Neurology 2004; 62: 809–810.

    Article  CAS  Google Scholar 

  16. Baldassano RN, Bradfield JP, Monos DS, Kim CE, Glessner JT, Casalunovo T et al. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric crohn's disease. Clin Gastroenterol Hepatol 2007; 5: 972–976.

    Article  CAS  Google Scholar 

  17. Borgiani P, Perricone C, Ciccacci C, Romano S, Novelli G, Biancone L et al. Interleukin-23R Arg381Gln is associated with susceptibility to Crohn's disease but not with phenotype in an Italian population. Gastroenterology 2007; 133: 1049–1051; author reply 1051–1042.

    Article  CAS  Google Scholar 

  18. Cummings JR, Ahmad T, Geremia A, Beckly J, Cooney R, Hancock L et al. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. Inflamm Bowel Dis 2007; 13: 1063–1068.

    Article  Google Scholar 

  19. Dubinsky MC, Wang D, Picornell Y, Wrobel I, Katzir L, Quiros A et al. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease. Inflamm Bowel Dis 2007; 13: 511–515.

    Article  Google Scholar 

  20. Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A et al. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 2007; 132: 1657–1664.

    Article  CAS  Google Scholar 

  21. Van Limbergen J, Russell RK, Nimmo ER, Drummond HE, Smith L, Davies G et al. IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. Gut 2007; 56: 1173–1174.

    Article  CAS  Google Scholar 

  22. Yamazaki K, Onouchi Y, Takazoe M, Kubo M, Nakamura Y, Hata A . Association analysis of genetic variants in IL23R, ATG16L1 and 5p13. 1 loci with Crohn's disease in Japanese patients. J Hum Genet 2007; 52: 575–583.

    Article  CAS  Google Scholar 

  23. Glas J, Seiderer J, Wetzke M, Konrad A, Torok HP, Schmechel S et al. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS ONE 2007; 2: e819.

    Article  Google Scholar 

  24. Raelson JV, Little RD, Ruether A, Fournier H, Paquin B, Van Eerdewegh P et al. Genome-wide association study for Crohn's disease in the Quebec founder population identifies multiple validated disease loci. Proc Natl Acad Sci USA 2007; 104: 14747–14752.

    Article  CAS  Google Scholar 

  25. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744–748.

    Article  CAS  Google Scholar 

  26. Heremans H, Dillen C, Groenen M, Martens E, Billiau A . Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma. Eur J Immunol 1996; 26: 2393–2398.

    Article  CAS  Google Scholar 

  27. Panitch HS, Hirsch RL, Haley AS, Johnson KP . Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987; 1: 893–895.

    Article  CAS  Google Scholar 

  28. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235–238.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are most grateful to Carmen Martínez Cuervo for her expert technical assistance. This work was supported by grants from ‘Fundación Ramón Areces’ and from FIS (PI070353). Concepción Núñez and Alfonso Martínez have a FIS contract (CA06/0163 and 0CP04/00175, respectively) and Elena Urcelay works for the ‘Fundación para la Investigación Biomédica-Hospital Clínico San Carlos’. Bárbara Dema receives a grant from ‘Fundación Mutua Madrileña’.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Núñez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Núñez, C., Dema, B., Cénit, M. et al. IL23R: a susceptibility locus for celiac disease and multiple sclerosis?. Genes Immun 9, 289–293 (2008). https://doi.org/10.1038/gene.2008.16

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gene.2008.16

Keywords

This article is cited by

Search

Quick links